<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
<journal-id journal-id-type="nlm-ta">Nature</journal-id>
<journal-id journal-id-type="iso-abbrev">Nature</journal-id>
<journal-title-group>
<journal-title>Nature</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-0836</issn>
<issn pub-type="epub">1476-4687</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29562236</article-id>
<article-id pub-id-type="pmc">5912909</article-id>
<article-id pub-id-type="doi">10.1038/nature25983</article-id>
<article-id pub-id-type="manuscript">NIHMS958806</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De novo</italic> mutations in regulatory elements in neurodevelopmental disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Short</surname>
<given-names>Patrick J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McRae</surname>
<given-names>Jeremy F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallone</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sifrim</surname>
<given-names>Alejandro</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Won</surname>
<given-names>Hyejung</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geschwind</surname>
<given-names>Daniel H.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wright</surname>
<given-names>Caroline F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Firth</surname>
<given-names>Helen V</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>FitzPatrick</surname>
<given-names>David R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrett</surname>
<given-names>Jeffrey C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hurles</surname>
<given-names>Matthew E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK</aff>
<aff id="A2">
<label>2</label>Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA</aff>
<aff id="A3">
<label>3</label>Center for Autism Research and Treatment, Program in Neurobehavioral Genetics, Semel Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA</aff>
<aff id="A4">
<label>4</label>Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA</aff>
<aff id="A5">
<label>5</label>Institute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Level 4, Royal Devon &amp; Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK</aff>
<aff id="A6">
<label>6</label>East Anglian Medical Genetics Service, Box 134, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK</aff>
<aff id="A7">
<label>7</label>MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK</aff>
<author-notes>
<corresp id="FN1">Correspondence and requests for materials should be addressed to M.E.H. (<email>meh@sanger.ac.uk</email>)</corresp>
<fn fn-type="COI-statement" id="FN5">
<p>The authors declare competing financial interests: details are available in the online version of the paper. Readers are welcome to comment on the online version of the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>29</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>23</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>555</volume>
<issue>7698</issue>
<fpage>611</fpage>
<lpage>616</lpage>
<!--elocation-id from pubmed: 10.1038/nature25983-->
<permissions>
<license license-type="permissions-link">
<license-p>Reprints and permissions information is available at <ext-link ext-link-type="uri" xlink:href="www.nature.com/reprints">www.nature.com/reprints</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">We previously estimated that 42% of patients with severe developmental disorders carry pathogenic <italic>de novo</italic> mutations in coding sequences. The role of <italic>de novo</italic> mutations in regulatory elements affecting genes associated with developmental disorders, or other genes, has been essentially unexplored. We identified <italic>de novo</italic> mutations in three classes of putative regulatory elements in almost 8,000 patients with developmental disorders. Here we show that <italic>de novo</italic> mutations in highly evolutionarily conserved fetal brain-active elements are significantly and specifically enriched in neurodevelopmental disorders. We identified a significant twofold enrichment of recurrently mutated elements. We estimate that, genome-wide, 1-3% of patients without a diagnostic coding variant carry pathogenic <italic>de novo</italic> mutations in fetal brain-active regulatory elements and that only 0.15% of all possible mutations within highly conserved fetal brain-active elements cause neurodevelopmental disorders with a dominant mechanism. Our findings represent a robust estimate of the contribution of <italic>de novo</italic> mutations in regulatory elements to this genetically heterogeneous set of disorders, and emphasize the importance of combining functional and evolutionary evidence to identify regulatory causes of genetic disorders.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>